Skip to main content

Olanzapine in the treatment-resistant, combat-related PTSD – a series of case reports

Buy Article:

$51.00 plus tax (Refund Policy)


Jakovljević M, Šagud M, Mihaljević-Peleš A. Olanzapine in the treatment-resistant, combat-related PTSD – a series of case reports.

Acta Psychiatr Scand 2003: 107: 394–396. © Blackwell Munksgaard 2003. Objective: 

Nightmares and insomnia in combat-related post-traumatic stress disorder (PTSD) might be resistant to treatment with selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines. Method: 

We describe five case reports of patients suffering from long-lasting and intractable nightmares and insomnia. They were given different psychotropic agents in past few years, with no improvement in their sleep disturbance. Olanzapine was added to the current treatment regimen. Results: 

Both nightmares and insomnia improved rapidly after olanzapine institution in all of five patients. No adverse events of olanzapine were reported. Conclusion: 

Olanzapine augmentation might be useful in alleviating treatment-resistant nightmares and insomnia in patients with combat-related PTSD.

Keywords: insomnia; nightmares; olanzapine; post-traumatic stress disorder

Document Type: Case Report


Affiliations: Department of Psychiatry, University Hospital Center Zagreb, Zagreb-Rebro, Croatia

Publication date: May 1, 2003

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more